Several studies have reported that GPR37 is implicated in the pathogenesis of Parkinson's disease (PD) (Kitao et al., 2007; Murakami et al., 2004; Wang et al., 2008), the second most common neurodegenerative disorder that is characterized by dopaminergic cell death. Here, GPR37 is linked to Parkinson disease.